Fluvoxamine for the treatment of COVID-19.
Nyirenda JL, Sofroniou M, Toews I, Mikolajewska A, Lehane C, Monsef I, Abu-Taha A, Maun A, Stegemann M, Schmucker C.
Nyirenda JL, et al.
Cochrane Database Syst Rev. 2022 Sep 14;9(9):CD015391. doi: 10.1002/14651858.CD015391.
Cochrane Database Syst Rev. 2022.
PMID: 36103313
Free PMC article.
Review.